CHU Besançon ( Site 0305)

Besançon, Doubs 25000

0 studies enrolling now · 1 studies all time

What they study most

Prostate Cancer, Prostatic Neoplasms

Studies at this site

• A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001) — Recruiting now